載入...
Immune Checkpoint Inhibitors in NSCLC
Lung cancer is the leading cause of cancer-related mortality worldwide. Cytotoxic chemotherapy and tyrosine kinase inhibitors provide palliation and prolong survival, however, the median survival for patients with metastatic disease remains poor and more effective therapies are needed. Immune checkp...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4216599/ https://ncbi.nlm.nih.gov/pubmed/25096781 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-014-0305-5 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|